Optic neuropathy

Gene: AFG3L2

Green List (high evidence)

AFG3L2 (AFG3 like matrix AAA peptidase subunit 2)
EnsemblGeneIds (GRCh38): ENSG00000141385
EnsemblGeneIds (GRCh37): ENSG00000141385
OMIM: 604581, Gene2Phenotype
AFG3L2 is in 20 panels

4 reviews

Ivone Leong (Genomics England Curator)

Green List (high evidence)

The rating of this gene has been updated following NHS Genomic Medicine Service approval.
Created: 8 Mar 2022, 10:01 a.m. | Last Modified: 8 Mar 2022, 10:01 a.m.
Panel Version: 2.58
This gene is associated with an appropriate phenotype in OMIM. There are >3 cases supporting a gene-disease association (PMID: 29181157, 26539208, 30252181, 32600459, 32219868, 32548275). This gene will be promoted to Green gene status at the next big review of the panel and has been tagged with "for-review".
Created: 25 Aug 2020, 10:08 a.m. | Last Modified: 25 Aug 2020, 10:08 a.m.
Panel Version: 2.27

Sara Martins (All Wales Medical Genomics Service)

Green List (high evidence)

Another report supporting association of AFG3L2 with optic neuropathies. Caporali et al (2020) (PMID 32219868) reported several families with optic atrophy associated with AFG3L2 variants. Phenotypes ranged from isolated optic atrophy to optic atrophy associated with hearing loss, intellectual disability and ataxia, among others. Functional studies in yeast showed that variants found in this study affect AFG3L2 function (p.D407G, p.A462V, p.R465K, p.P514L, p.Q620K).
Created: 23 Jun 2020, 1:07 p.m. | Last Modified: 23 Jun 2020, 1:07 p.m.
Panel Version: 2.3

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246)

Publications

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Three families reported with a recurrent missense variant associated with OA, R468C. The variant was de novo in at least one family, suggesting this is not a founder variant, but a specific residue that is functionally important in the pathogenesis of OA. Note the evidence so far is for this specific variant only, and in at least one family, the clinical presentation was with isolated OA.
Created: 16 Apr 2020, 12:15 a.m. | Last Modified: 16 Apr 2020, 12:15 a.m.
Panel Version: 2.3

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Spastic ataxia 5, autosomal recessive (MIM#614487); Spinocerebellar ataxia 28 (MIM#610246)

Publications

Variants in this GENE are reported as part of current diagnostic practice

Tom Cullup (Great Ormond Street Hospital)

I don't know

Some reports in literature, but possibly not enough to satisfy criteria. Additional unpublished families identified through testing (PYWM).
Created: 19 Mar 2019, 3:33 p.m.

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE, 614487; SPINOCEREBELLAR ATAXIA 28, 610246

Publications

History Filter Activity

19 Apr 2022, Gel status: 3

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: AFG3L2 were changed from Optic atrophy 12, 618977 to Optic atrophy 12, OMIM:618977 (AD); Spastic ataxia 5, autosomal recessive, OMIM:614487 (AR)

8 Mar 2022, Gel status: 3

Removed Tag

Ivone Leong (Genomics England Curator)

Tag for-review was removed from gene: AFG3L2.

8 Mar 2022, Gel status: 3

Added New Source, Status Update

Ivone Leong (Genomics England Curator)

Source Expert Review Green was added to AFG3L2. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)

25 Aug 2020, Gel status: 2

Added Tag

Ivone Leong (Genomics England Curator)

Tag for-review tag was added to gene: AFG3L2.

25 Aug 2020, Gel status: 2

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: AFG3L2 were set to 29181157; 26539208; 30544562; 30252181; 30389403; 30252181; 30389403; 32219868

25 Aug 2020, Gel status: 2

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: AFG3L2 were set to 29181157; 26539208; 30544562; 30252181; 30389403; 30252181; 30389403

25 Aug 2020, Gel status: 2

Set Phenotypes

Ivone Leong (Genomics England Curator)

Phenotypes for gene: AFG3L2 were changed from Spastic ataxia 5, autosomal recessive, 614487; Spinocerebellar ataxia 28, 610246 to Optic atrophy 12, 618977

14 Jul 2020, Gel status: 2

Set Phenotypes

Ivone Leong (Genomics England Curator)

Phenotypes for gene: AFG3L2 were changed from SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE, 614487; SPINOCEREBELLAR ATAXIA 28, 610246 to Spastic ataxia 5, autosomal recessive, 614487; Spinocerebellar ataxia 28, 610246

14 Jul 2020, Gel status: 2

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: AFG3L2 were set to 29181157; 26539208; 30544562

19 Mar 2019, Gel status: 2

Set Phenotypes

Ivone Leong (Genomics England Curator)

Phenotypes for gene: AFG3L2 were changed from to SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE, 614487; SPINOCEREBELLAR ATAXIA 28, 610246

19 Mar 2019, Gel status: 2

Set publications

Ivone Leong (Genomics England Curator)

Publications for gene: AFG3L2 were set to

19 Mar 2019, Gel status: 2

Set mode of inheritance

Ivone Leong (Genomics England Curator)

Mode of inheritance for gene: AFG3L2 was changed from to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

19 Mar 2019, Gel status: 2

Created, Added New Source, Set mode of inheritance

Ivone Leong (Genomics England Curator)

gene: AFG3L2 was added gene: AFG3L2 was added to Optic neuropathy. Sources: London North GLH,Expert Review Amber Mode of inheritance for gene: AFG3L2 was set to